nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—SLC6A4—chronic obstructive pulmonary disease	0.225	0.523	CbGaD
Citalopram—CYP1A2—chronic obstructive pulmonary disease	0.205	0.477	CbGaD
Citalopram—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0594	0.172	CbGbCtD
Citalopram—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.04	0.116	CbGbCtD
Citalopram—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0295	0.0852	CbGbCtD
Citalopram—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0295	0.0852	CbGbCtD
Citalopram—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0231	0.0668	CbGbCtD
Citalopram—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0224	0.0648	CbGbCtD
Citalopram—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0224	0.0648	CbGbCtD
Citalopram—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.02	0.0577	CbGbCtD
Citalopram—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0188	0.0543	CbGbCtD
Citalopram—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0127	0.0367	CbGbCtD
Citalopram—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0124	0.0358	CbGbCtD
Citalopram—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0121	0.035	CbGbCtD
Citalopram—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0108	0.0312	CbGbCtD
Citalopram—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0106	0.0306	CbGbCtD
Citalopram—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00999	0.0289	CbGbCtD
Citalopram—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00634	0.0183	CbGbCtD
Citalopram—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00599	0.0173	CbGbCtD
Citalopram—Escitalopram—SLC6A4—chronic obstructive pulmonary disease	0.00277	1	CrCbGaD
Citalopram—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	7.19e-05	0.0004	CcSEcCtD
Citalopram—Pruritus—Aminophylline—chronic obstructive pulmonary disease	7.15e-05	0.000399	CcSEcCtD
Citalopram—Shock—Salbutamol—chronic obstructive pulmonary disease	7.15e-05	0.000398	CcSEcCtD
Citalopram—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	7.14e-05	0.000398	CcSEcCtD
Citalopram—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	7.13e-05	0.000397	CcSEcCtD
Citalopram—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	7.09e-05	0.000395	CcSEcCtD
Citalopram—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000395	CcSEcCtD
Citalopram—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	7.06e-05	0.000393	CcSEcCtD
Citalopram—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	7.03e-05	0.000391	CcSEcCtD
Citalopram—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	7.03e-05	0.000391	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	7.01e-05	0.000391	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	7.01e-05	0.000391	CcSEcCtD
Citalopram—Insomnia—Formoterol—chronic obstructive pulmonary disease	6.96e-05	0.000388	CcSEcCtD
Citalopram—Insomnia—Arformoterol—chronic obstructive pulmonary disease	6.96e-05	0.000388	CcSEcCtD
Citalopram—Anorexia—Salbutamol—chronic obstructive pulmonary disease	6.93e-05	0.000386	CcSEcCtD
Citalopram—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	6.92e-05	0.000386	CcSEcCtD
Citalopram—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	6.89e-05	0.000384	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.87e-05	0.000383	CcSEcCtD
Citalopram—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	6.86e-05	0.000382	CcSEcCtD
Citalopram—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	6.86e-05	0.000382	CcSEcCtD
Citalopram—Somnolence—Arformoterol—chronic obstructive pulmonary disease	6.84e-05	0.000381	CcSEcCtD
Citalopram—Somnolence—Formoterol—chronic obstructive pulmonary disease	6.84e-05	0.000381	CcSEcCtD
Citalopram—Insomnia—Montelukast—chronic obstructive pulmonary disease	6.82e-05	0.00038	CcSEcCtD
Citalopram—Hypotension—Salbutamol—chronic obstructive pulmonary disease	6.79e-05	0.000378	CcSEcCtD
Citalopram—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	6.77e-05	0.000377	CcSEcCtD
Citalopram—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	6.77e-05	0.000377	CcSEcCtD
Citalopram—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	6.77e-05	0.000377	CcSEcCtD
Citalopram—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.75e-05	0.000376	CcSEcCtD
Citalopram—Injury—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000374	CcSEcCtD
Citalopram—Somnolence—Montelukast—chronic obstructive pulmonary disease	6.7e-05	0.000373	CcSEcCtD
Citalopram—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.69e-05	0.000373	CcSEcCtD
Citalopram—Weight increased—Prednisolone—chronic obstructive pulmonary disease	6.67e-05	0.000372	CcSEcCtD
Citalopram—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.64e-05	0.00037	CcSEcCtD
Citalopram—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.64e-05	0.00037	CcSEcCtD
Citalopram—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.64e-05	0.00037	CcSEcCtD
Citalopram—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.64e-05	0.00037	CcSEcCtD
Citalopram—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.64e-05	0.00037	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.62e-05	0.000369	CcSEcCtD
Citalopram—Constipation—Formoterol—chronic obstructive pulmonary disease	6.58e-05	0.000367	CcSEcCtD
Citalopram—Pain—Formoterol—chronic obstructive pulmonary disease	6.58e-05	0.000367	CcSEcCtD
Citalopram—Constipation—Arformoterol—chronic obstructive pulmonary disease	6.58e-05	0.000367	CcSEcCtD
Citalopram—Pain—Arformoterol—chronic obstructive pulmonary disease	6.58e-05	0.000367	CcSEcCtD
Citalopram—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.57e-05	0.000366	CcSEcCtD
Citalopram—Increased appetite—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000365	CcSEcCtD
Citalopram—Amnesia—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000365	CcSEcCtD
Citalopram—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	6.53e-05	0.000364	CcSEcCtD
Citalopram—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.51e-05	0.000363	CcSEcCtD
Citalopram—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.5e-05	0.000362	CcSEcCtD
Citalopram—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6.48e-05	0.000361	CcSEcCtD
Citalopram—Somnolence—Salbutamol—chronic obstructive pulmonary disease	6.46e-05	0.00036	CcSEcCtD
Citalopram—Pain—Montelukast—chronic obstructive pulmonary disease	6.45e-05	0.000359	CcSEcCtD
Citalopram—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000359	CcSEcCtD
Citalopram—Vomiting—Aminophylline—chronic obstructive pulmonary disease	6.43e-05	0.000358	CcSEcCtD
Citalopram—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000357	CcSEcCtD
Citalopram—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000357	CcSEcCtD
Citalopram—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	6.4e-05	0.000356	CcSEcCtD
Citalopram—Purpura—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.000356	CcSEcCtD
Citalopram—Rash—Aminophylline—chronic obstructive pulmonary disease	6.38e-05	0.000355	CcSEcCtD
Citalopram—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6.37e-05	0.000355	CcSEcCtD
Citalopram—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	6.35e-05	0.000354	CcSEcCtD
Citalopram—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	6.34e-05	0.000353	CcSEcCtD
Citalopram—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	6.34e-05	0.000353	CcSEcCtD
Citalopram—Headache—Aminophylline—chronic obstructive pulmonary disease	6.34e-05	0.000353	CcSEcCtD
Citalopram—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	6.32e-05	0.000352	CcSEcCtD
Citalopram—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000352	CcSEcCtD
Citalopram—Dizziness—Tiotropium—chronic obstructive pulmonary disease	6.31e-05	0.000351	CcSEcCtD
Citalopram—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	6.29e-05	0.000351	CcSEcCtD
Citalopram—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	6.29e-05	0.000351	CcSEcCtD
Citalopram—Lethargy—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.00035	CcSEcCtD
Citalopram—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	6.27e-05	0.00035	CcSEcCtD
Citalopram—Fatigue—Salbutamol—chronic obstructive pulmonary disease	6.27e-05	0.000349	CcSEcCtD
Citalopram—Constipation—Salbutamol—chronic obstructive pulmonary disease	6.21e-05	0.000346	CcSEcCtD
Citalopram—Pain—Salbutamol—chronic obstructive pulmonary disease	6.21e-05	0.000346	CcSEcCtD
Citalopram—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	6.16e-05	0.000343	CcSEcCtD
Citalopram—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000343	CcSEcCtD
Citalopram—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000343	CcSEcCtD
Citalopram—Urticaria—Arformoterol—chronic obstructive pulmonary disease	6.11e-05	0.000341	CcSEcCtD
Citalopram—Urticaria—Formoterol—chronic obstructive pulmonary disease	6.11e-05	0.000341	CcSEcCtD
Citalopram—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	6.08e-05	0.000339	CcSEcCtD
Citalopram—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	6.08e-05	0.000339	CcSEcCtD
Citalopram—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	6.08e-05	0.000339	CcSEcCtD
Citalopram—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	6.08e-05	0.000339	CcSEcCtD
Citalopram—Affect lability—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000338	CcSEcCtD
Citalopram—Vomiting—Tiotropium—chronic obstructive pulmonary disease	6.06e-05	0.000338	CcSEcCtD
Citalopram—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000335	CcSEcCtD
Citalopram—Rash—Tiotropium—chronic obstructive pulmonary disease	6.01e-05	0.000335	CcSEcCtD
Citalopram—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	6.01e-05	0.000335	CcSEcCtD
Citalopram—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.01e-05	0.000335	CcSEcCtD
Citalopram—Urticaria—Montelukast—chronic obstructive pulmonary disease	5.99e-05	0.000334	CcSEcCtD
Citalopram—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	5.99e-05	0.000334	CcSEcCtD
Citalopram—Headache—Tiotropium—chronic obstructive pulmonary disease	5.97e-05	0.000333	CcSEcCtD
Citalopram—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	5.97e-05	0.000333	CcSEcCtD
Citalopram—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	5.96e-05	0.000332	CcSEcCtD
Citalopram—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	5.96e-05	0.000332	CcSEcCtD
Citalopram—Face oedema—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000331	CcSEcCtD
Citalopram—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	5.94e-05	0.000331	CcSEcCtD
Citalopram—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	5.9e-05	0.000329	CcSEcCtD
Citalopram—Irritability—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000328	CcSEcCtD
Citalopram—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000327	CcSEcCtD
Citalopram—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000326	CcSEcCtD
Citalopram—Mood swings—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000325	CcSEcCtD
Citalopram—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.77e-05	0.000322	CcSEcCtD
Citalopram—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	5.74e-05	0.00032	CcSEcCtD
Citalopram—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.74e-05	0.00032	CcSEcCtD
Citalopram—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.67e-05	0.000316	CcSEcCtD
Citalopram—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.67e-05	0.000316	CcSEcCtD
Citalopram—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.66e-05	0.000316	CcSEcCtD
Citalopram—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	5.65e-05	0.000315	CcSEcCtD
Citalopram—Dry skin—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000315	CcSEcCtD
Citalopram—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000312	CcSEcCtD
Citalopram—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.55e-05	0.000309	CcSEcCtD
Citalopram—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.52e-05	0.000308	CcSEcCtD
Citalopram—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.52e-05	0.000308	CcSEcCtD
Citalopram—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.45e-05	0.000303	CcSEcCtD
Citalopram—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.45e-05	0.000303	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000303	CcSEcCtD
Citalopram—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000303	CcSEcCtD
Citalopram—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.41e-05	0.000301	CcSEcCtD
Citalopram—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000299	CcSEcCtD
Citalopram—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	5.35e-05	0.000298	CcSEcCtD
Citalopram—Pruritus—Montelukast—chronic obstructive pulmonary disease	5.33e-05	0.000297	CcSEcCtD
Citalopram—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	5.27e-05	0.000293	CcSEcCtD
Citalopram—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	5.27e-05	0.000293	CcSEcCtD
Citalopram—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	5.24e-05	0.000292	CcSEcCtD
Citalopram—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000291	CcSEcCtD
Citalopram—Asthenia—Salbutamol—chronic obstructive pulmonary disease	5.21e-05	0.000291	CcSEcCtD
Citalopram—Sweating increased—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000289	CcSEcCtD
Citalopram—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5.16e-05	0.000287	CcSEcCtD
Citalopram—Pruritus—Salbutamol—chronic obstructive pulmonary disease	5.14e-05	0.000286	CcSEcCtD
Citalopram—Erythema—Prednisolone—chronic obstructive pulmonary disease	5.11e-05	0.000285	CcSEcCtD
Citalopram—Dizziness—Arformoterol—chronic obstructive pulmonary disease	5.09e-05	0.000284	CcSEcCtD
Citalopram—Dizziness—Formoterol—chronic obstructive pulmonary disease	5.09e-05	0.000284	CcSEcCtD
Citalopram—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.98e-05	0.000278	CcSEcCtD
Citalopram—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.97e-05	0.000277	CcSEcCtD
Citalopram—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000273	CcSEcCtD
Citalopram—Vomiting—Formoterol—chronic obstructive pulmonary disease	4.89e-05	0.000273	CcSEcCtD
Citalopram—Vomiting—Arformoterol—chronic obstructive pulmonary disease	4.89e-05	0.000273	CcSEcCtD
Citalopram—Rash—Formoterol—chronic obstructive pulmonary disease	4.85e-05	0.00027	CcSEcCtD
Citalopram—Rash—Arformoterol—chronic obstructive pulmonary disease	4.85e-05	0.00027	CcSEcCtD
Citalopram—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.85e-05	0.00027	CcSEcCtD
Citalopram—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.85e-05	0.00027	CcSEcCtD
Citalopram—Weight increased—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.00027	CcSEcCtD
Citalopram—Headache—Arformoterol—chronic obstructive pulmonary disease	4.82e-05	0.000269	CcSEcCtD
Citalopram—Headache—Formoterol—chronic obstructive pulmonary disease	4.82e-05	0.000269	CcSEcCtD
Citalopram—Weight decreased—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000268	CcSEcCtD
Citalopram—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.81e-05	0.000268	CcSEcCtD
Citalopram—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.81e-05	0.000268	CcSEcCtD
Citalopram—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000268	CcSEcCtD
Citalopram—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.79e-05	0.000267	CcSEcCtD
Citalopram—Rash—Montelukast—chronic obstructive pulmonary disease	4.75e-05	0.000265	CcSEcCtD
Citalopram—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.75e-05	0.000265	CcSEcCtD
Citalopram—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	4.74e-05	0.000264	CcSEcCtD
Citalopram—Depression—Prednisone—chronic obstructive pulmonary disease	4.74e-05	0.000264	CcSEcCtD
Citalopram—Headache—Montelukast—chronic obstructive pulmonary disease	4.72e-05	0.000263	CcSEcCtD
Citalopram—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000261	CcSEcCtD
Citalopram—Angioedema—Prednisolone—chronic obstructive pulmonary disease	4.67e-05	0.00026	CcSEcCtD
Citalopram—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000259	CcSEcCtD
Citalopram—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000259	CcSEcCtD
Citalopram—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.62e-05	0.000257	CcSEcCtD
Citalopram—Malaise—Prednisolone—chronic obstructive pulmonary disease	4.61e-05	0.000257	CcSEcCtD
Citalopram—Vertigo—Prednisolone—chronic obstructive pulmonary disease	4.59e-05	0.000256	CcSEcCtD
Citalopram—Rash—Salbutamol—chronic obstructive pulmonary disease	4.58e-05	0.000255	CcSEcCtD
Citalopram—Syncope—Prednisolone—chronic obstructive pulmonary disease	4.58e-05	0.000255	CcSEcCtD
Citalopram—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.58e-05	0.000255	CcSEcCtD
Citalopram—Nausea—Formoterol—chronic obstructive pulmonary disease	4.57e-05	0.000255	CcSEcCtD
Citalopram—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.57e-05	0.000255	CcSEcCtD
Citalopram—Headache—Salbutamol—chronic obstructive pulmonary disease	4.55e-05	0.000254	CcSEcCtD
Citalopram—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	4.49e-05	0.00025	CcSEcCtD
Citalopram—Nausea—Montelukast—chronic obstructive pulmonary disease	4.48e-05	0.000249	CcSEcCtD
Citalopram—Convulsion—Prednisolone—chronic obstructive pulmonary disease	4.42e-05	0.000247	CcSEcCtD
Citalopram—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.41e-05	0.000246	CcSEcCtD
Citalopram—Bradycardia—Prednisone—chronic obstructive pulmonary disease	4.34e-05	0.000242	CcSEcCtD
Citalopram—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.32e-05	0.000241	CcSEcCtD
Citalopram—Discomfort—Prednisolone—chronic obstructive pulmonary disease	4.3e-05	0.000239	CcSEcCtD
Citalopram—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000239	CcSEcCtD
Citalopram—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.26e-05	0.000238	CcSEcCtD
Citalopram—Hallucination—Prednisone—chronic obstructive pulmonary disease	4.24e-05	0.000236	CcSEcCtD
Citalopram—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000233	CcSEcCtD
Citalopram—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	4.17e-05	0.000232	CcSEcCtD
Citalopram—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.17e-05	0.000232	CcSEcCtD
Citalopram—Shock—Prednisolone—chronic obstructive pulmonary disease	4.1e-05	0.000228	CcSEcCtD
Citalopram—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	4.07e-05	0.000227	CcSEcCtD
Citalopram—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	4.03e-05	0.000225	CcSEcCtD
Citalopram—Eye disorder—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.000222	CcSEcCtD
Citalopram—Flushing—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.00022	CcSEcCtD
Citalopram—Angiopathy—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000216	CcSEcCtD
Citalopram—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000215	CcSEcCtD
Citalopram—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.000212	CcSEcCtD
Citalopram—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.77e-05	0.00021	CcSEcCtD
Citalopram—Alopecia—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.00021	CcSEcCtD
Citalopram—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.74e-05	0.000209	CcSEcCtD
Citalopram—Mental disorder—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000208	CcSEcCtD
Citalopram—Erythema—Prednisone—chronic obstructive pulmonary disease	3.71e-05	0.000207	CcSEcCtD
Citalopram—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.71e-05	0.000207	CcSEcCtD
Citalopram—Pain—Prednisolone—chronic obstructive pulmonary disease	3.56e-05	0.000199	CcSEcCtD
Citalopram—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000195	CcSEcCtD
Citalopram—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	3.44e-05	0.000192	CcSEcCtD
Citalopram—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	3.43e-05	0.000191	CcSEcCtD
Citalopram—Anaemia—Prednisone—chronic obstructive pulmonary disease	3.43e-05	0.000191	CcSEcCtD
Citalopram—Agitation—Prednisone—chronic obstructive pulmonary disease	3.41e-05	0.00019	CcSEcCtD
Citalopram—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.39e-05	0.000189	CcSEcCtD
Citalopram—Malaise—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000186	CcSEcCtD
Citalopram—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000186	CcSEcCtD
Citalopram—Syncope—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000185	CcSEcCtD
Citalopram—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.31e-05	0.000184	CcSEcCtD
Citalopram—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000182	CcSEcCtD
Citalopram—Convulsion—Prednisone—chronic obstructive pulmonary disease	3.22e-05	0.000179	CcSEcCtD
Citalopram—Hypertension—Prednisone—chronic obstructive pulmonary disease	3.2e-05	0.000179	CcSEcCtD
Citalopram—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000176	CcSEcCtD
Citalopram—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000176	CcSEcCtD
Citalopram—Anxiety—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000175	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000175	CcSEcCtD
Citalopram—Discomfort—Prednisone—chronic obstructive pulmonary disease	3.12e-05	0.000174	CcSEcCtD
Citalopram—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	3.07e-05	0.000171	CcSEcCtD
Citalopram—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000169	CcSEcCtD
Citalopram—Oedema—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000169	CcSEcCtD
Citalopram—Infection—Prednisone—chronic obstructive pulmonary disease	3.01e-05	0.000168	CcSEcCtD
Citalopram—Shock—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000166	CcSEcCtD
Citalopram—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000165	CcSEcCtD
Citalopram—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.96e-05	0.000165	CcSEcCtD
Citalopram—Skin disorder—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000164	CcSEcCtD
Citalopram—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.93e-05	0.000163	CcSEcCtD
Citalopram—Anorexia—Prednisone—chronic obstructive pulmonary disease	2.89e-05	0.000161	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.76e-05	0.000154	CcSEcCtD
Citalopram—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.76e-05	0.000154	CcSEcCtD
Citalopram—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.74e-05	0.000153	CcSEcCtD
Citalopram—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000152	CcSEcCtD
Citalopram—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000149	CcSEcCtD
Citalopram—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.63e-05	0.000147	CcSEcCtD
Citalopram—Rash—Prednisolone—chronic obstructive pulmonary disease	2.63e-05	0.000146	CcSEcCtD
Citalopram—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.63e-05	0.000146	CcSEcCtD
Citalopram—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.61e-05	0.000145	CcSEcCtD
Citalopram—Headache—Prednisolone—chronic obstructive pulmonary disease	2.61e-05	0.000145	CcSEcCtD
Citalopram—Constipation—Prednisone—chronic obstructive pulmonary disease	2.59e-05	0.000144	CcSEcCtD
Citalopram—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.000139	CcSEcCtD
Citalopram—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.48e-05	0.000138	CcSEcCtD
Citalopram—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.48e-05	0.000138	CcSEcCtD
Citalopram—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.41e-05	0.000134	CcSEcCtD
Citalopram—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.39e-05	0.000133	CcSEcCtD
Citalopram—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.39e-05	0.000133	CcSEcCtD
Citalopram—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.23e-05	0.00054	CbGpPWpGaD
Citalopram—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000124	CcSEcCtD
Citalopram—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.2e-05	0.000533	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.2e-05	0.000532	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.2e-05	0.000532	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.19e-05	0.00053	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.19e-05	0.000529	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.18e-05	0.000526	CbGpPWpGaD
Citalopram—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.17e-05	0.000121	CcSEcCtD
Citalopram—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.17e-05	0.000525	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.17e-05	0.000524	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000522	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.14e-05	0.000518	CbGpPWpGaD
Citalopram—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.14e-05	0.000119	CcSEcCtD
Citalopram—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.14e-05	0.000516	CbGpPWpGaD
Citalopram—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.07e-05	0.000115	CcSEcCtD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.04e-05	0.000492	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.04e-05	0.000492	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.02e-05	0.000489	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.01e-05	0.000486	CbGpPWpGaD
Citalopram—Dizziness—Prednisone—chronic obstructive pulmonary disease	2e-05	0.000112	CcSEcCtD
Citalopram—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2e-05	0.000483	CbGpPWpGaD
Citalopram—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2e-05	0.000483	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.99e-05	0.000482	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.93e-05	0.000465	CbGpPWpGaD
Citalopram—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.93e-05	0.000107	CcSEcCtD
Citalopram—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.000464	CbGpPWpGaD
Citalopram—Rash—Prednisone—chronic obstructive pulmonary disease	1.91e-05	0.000106	CcSEcCtD
Citalopram—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.91e-05	0.000106	CcSEcCtD
Citalopram—Headache—Prednisone—chronic obstructive pulmonary disease	1.9e-05	0.000106	CcSEcCtD
Citalopram—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.89e-05	0.000457	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000442	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.82e-05	0.000439	CbGpPWpGaD
Citalopram—Nausea—Prednisone—chronic obstructive pulmonary disease	1.8e-05	0.0001	CcSEcCtD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.77e-05	0.000427	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.000425	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000424	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.74e-05	0.000421	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.74e-05	0.00042	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.73e-05	0.000419	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.71e-05	0.000413	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.7e-05	0.000411	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000408	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.67e-05	0.000403	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.66e-05	0.000402	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.66e-05	0.000401	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.65e-05	0.0004	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.65e-05	0.000398	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.64e-05	0.000396	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.62e-05	0.000392	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.00039	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.57e-05	0.00038	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.57e-05	0.000379	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.56e-05	0.000378	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.56e-05	0.000376	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.55e-05	0.000375	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.55e-05	0.000375	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.55e-05	0.000373	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.54e-05	0.000373	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.54e-05	0.000373	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.54e-05	0.000372	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	0.000372	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.52e-05	0.000368	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.5e-05	0.000363	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.47e-05	0.000356	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.43e-05	0.000345	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.43e-05	0.000345	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.42e-05	0.000344	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.000343	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.41e-05	0.000342	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.41e-05	0.00034	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.41e-05	0.00034	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.4e-05	0.000339	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.4e-05	0.000339	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.38e-05	0.000333	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.35e-05	0.000325	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.34e-05	0.000325	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.34e-05	0.000324	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.34e-05	0.000324	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.34e-05	0.000324	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.34e-05	0.000324	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.33e-05	0.000323	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.33e-05	0.00032	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.32e-05	0.000319	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000319	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.31e-05	0.000318	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.29e-05	0.000312	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.000311	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000311	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.28e-05	0.000308	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.27e-05	0.000307	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.25e-05	0.000303	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000298	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.23e-05	0.000297	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.23e-05	0.000296	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000296	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.21e-05	0.000292	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.21e-05	0.000292	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.2e-05	0.00029	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000289	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.18e-05	0.000286	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.17e-05	0.000283	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.00028	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.15e-05	0.000278	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.14e-05	0.000274	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.00027	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.11e-05	0.000269	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.1e-05	0.000265	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000261	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.000255	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.06e-05	0.000255	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.02e-05	0.000247	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.01e-05	0.000245	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.95e-06	0.00024	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.94e-06	0.00024	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.84e-06	0.000238	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.8e-06	0.000237	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.74e-06	0.000235	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.74e-06	0.000235	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.65e-06	0.000233	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.55e-06	0.000231	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.25e-06	0.000224	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.14e-06	0.000221	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.11e-06	0.00022	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.04e-06	0.000218	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.97e-06	0.000217	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8.94e-06	0.000216	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.82e-06	0.000213	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.77e-06	0.000212	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.72e-06	0.000211	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.7e-06	0.00021	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.44e-06	0.000204	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.41e-06	0.000203	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.33e-06	0.000201	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.31e-06	0.000201	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.29e-06	0.0002	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.28e-06	0.0002	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.22e-06	0.000199	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.18e-06	0.000198	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	8.15e-06	0.000197	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.12e-06	0.000196	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.01e-06	0.000194	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.96e-06	0.000192	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.96e-06	0.000192	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.91e-06	0.000191	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.73e-06	0.000187	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.62e-06	0.000184	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.61e-06	0.000184	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.6e-06	0.000184	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.57e-06	0.000183	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.54e-06	0.000182	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.52e-06	0.000182	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.51e-06	0.000182	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.5e-06	0.000181	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.46e-06	0.00018	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.45e-06	0.00018	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.4e-06	0.000179	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.33e-06	0.000177	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.22e-06	0.000175	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.08e-06	0.000171	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.07e-06	0.000171	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.04e-06	0.00017	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.96e-06	0.000168	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.91e-06	0.000167	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.9e-06	0.000167	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.88e-06	0.000166	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.85e-06	0.000166	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.83e-06	0.000165	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.77e-06	0.000164	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.73e-06	0.000163	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.6e-06	0.000159	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.58e-06	0.000159	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.49e-06	0.000157	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.47e-06	0.000156	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.35e-06	0.000154	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.27e-06	0.000151	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.18e-06	0.000149	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.13e-06	0.000148	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.12e-06	0.000148	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.11e-06	0.000148	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.03e-06	0.000146	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.02e-06	0.000145	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.82e-06	0.000141	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.76e-06	0.000139	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.76e-06	0.000139	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.68e-06	0.000137	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.62e-06	0.000136	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.55e-06	0.000134	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.46e-06	0.000132	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.44e-06	0.000131	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.37e-06	0.00013	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.33e-06	0.000129	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.3e-06	0.000128	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.3e-06	0.000128	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.04e-06	0.000122	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.03e-06	0.000121	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.02e-06	0.000121	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.95e-06	0.00012	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.91e-06	0.000119	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.9e-06	0.000118	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.88e-06	0.000118	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.81e-06	0.000116	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.81e-06	0.000116	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.81e-06	0.000116	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.8e-06	0.000116	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.72e-06	0.000114	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.7e-06	0.000114	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.7e-06	0.000113	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.6e-06	0.000111	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.59e-06	0.000111	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.58e-06	0.000111	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.52e-06	0.000109	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.51e-06	0.000109	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.49e-06	0.000108	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.47e-06	0.000108	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.25e-06	0.000103	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.25e-06	0.000103	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.08e-06	9.85e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.06e-06	9.82e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4e-06	9.66e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.88e-06	9.36e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.86e-06	9.33e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.82e-06	9.23e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.8e-06	9.19e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.77e-06	9.1e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.72e-06	8.98e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.71e-06	8.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.69e-06	8.91e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.67e-06	8.88e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.62e-06	8.75e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.62e-06	8.74e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-06	8.58e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.51e-06	8.47e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.46e-06	8.37e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.46e-06	8.37e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.44e-06	8.31e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.41e-06	8.25e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.31e-06	8e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.3e-06	7.97e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.28e-06	7.93e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.26e-06	7.89e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.25e-06	7.85e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.04e-06	7.34e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.03e-06	7.32e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.98e-06	7.2e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.98e-06	7.2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.97e-06	7.17e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.92e-06	7.06e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.89e-06	6.99e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.89e-06	6.97e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.77e-06	6.68e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.64e-06	6.38e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.5e-06	6.04e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.49e-06	6.02e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.45e-06	5.93e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.29e-06	5.53e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.28e-06	5.51e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.25e-06	5.43e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.23e-06	5.39e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.13e-06	5.16e-05	CbGpPWpGaD
